Here we go ladies and gents.
6 weeks to go at the latest, incorporating a wider array of respiratory diseases. New target 1500 patients to gain enough statistically significant pneumonia and croup patients.
Still on track for results and submission by the first half of this year.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Extends SMARTCOUGH-C Study
Ann: ResApp Extends SMARTCOUGH-C Study, page-2
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)